[Abstract] Hypoxia is a condition in which there is a decrease in oxygen supply to the cellular environment. Changes to cellular oxygen levels can lead to transcriptional changes of oxygen-regulated genes. Reporter assays are used to study gene expression alteration and modifications in response to environmental changes. Dual-reporter assays allow the simultaneous measurement of two different genes within a single cell, thus improving experimental accuracy. Within this protocol, we describe the utilization of the LightSwitch Dual Assay System to measure BMX expression in response to hypoxic conditions. Keywords: Luciferase, Reporter assay, Hypoxia, Regulation, Transcription be induced by ischemia and that sorafenib has antiangiogenic activity (He et al., 2006; Davis et al., 2011) . Therefore, we hypothesized that the antiangiogenic activity of sorafenib causes a hypoxic environment within the bone marrow, thus contributing to a hypoxia-dependent BMX upregulation in AML. Under hypoxic conditions, we were able to show a significant increase in BMX expression in a number of different cell lines. Further analysis of the BMX promoter identified a putative hypoxiaresponsive element (HRE; 5'-ACGTG-3') at -5005. To test whether this HRE was involved in the hypoxiainduced promoter activation of BMX, we developed a hypoxia element reporter assay.
regulation of BMX, a nonreceptor tyrosine kinase, in response to sorafenib treatment. BMX, a Tec kinase family member, is known bind to tyrosine-phosphorylated proteins and mediate membrane targeting by binding to phosphatidylinositol 3,4,5-triphosphate (PIP3; Chen et al., 2013) . We showed that direct treatment of sorafenib in acute myeloid leukemia (AML) cells lines with or without stromal cell support did not contribute to the upregulation of BMX. Previous studies have shown that BMX expression can be induced by ischemia and that sorafenib has antiangiogenic activity (He et al., 2006; Davis et al., 2011) . Therefore, we hypothesized that the antiangiogenic activity of sorafenib causes a hypoxic environment within the bone marrow, thus contributing to a hypoxia-dependent BMX upregulation in AML. Under hypoxic conditions, we were able to show a significant increase in BMX expression in a number of different cell lines. Further analysis of the BMX promoter identified a putative hypoxiaresponsive element (HRE; 5'-ACGTG-3') at -5005. To test whether this HRE was involved in the hypoxiainduced promoter activation of BMX, we developed a hypoxia element reporter assay.
Reporter assays are extensively used throughout the scientific community to study alterations and modifications to gene expression in response to environmental changes. One type of reporter assay that is gaining in acceptance are the dual-reporter assays. This type of reporter assay allows the simultaneous expression and measurement of two different reporters within a single cell and had been widely proven to improve experimental accuracy by reducing extraneous influences. One such dual assay system is the LightSwitch Dual Assay System. This system utilizes the RenSP luciferase reporter gene, a novel luciferase developed by SwitchGear Genomics and the Cypridina luciferase reporter gene. μl of growth media and cultured overnight at 37 °C in 5% CO2.
Day 2 Preparation of constructs and reagents
1. Allow all reagents and plasmids to equilibrate to room temperature.
Note: Plasmids should be purified using a kit or protocol that will remove endotoxin, such as
PureYeild Plasmid System from Promega. c. Gently drop onto seeded wells.
Pre-warm
d. Gently shake.
e. Plates should be incubated at 37 °C for 24 h in normoxia (5% CO2). 
Day 4
Follow the manufacturer's instructions (LightSwitch Dual Assay System) for measuring Renilla (pLightSwitch_Prom vectors) and Cypridina (pTK-Cluc) luciferase activity.
1. No alterations were made to the protocol detailed by SwitchGear Genomics. Plates were always measured fresh and never frozen.
2. For hypoxia conditions (all done within the hypoxia chamber):
a. Adding reagents and incubations are all done within the hypoxia chamber.
b. Remove the plates from hypoxia and immediately read the luminescence on a plate reader.
3. For normoxia conditions: Adding reagents and incubation are all done at room temperature on the bench top.
Data analysis
1. Renilla (pLightSwitch_Prom) luciferase activity is normalized to Cypridina (pTK-Cluc) luciferase activity and adjusted for background luciferase for each condition.
2. Data can then be graphed as relative luciferase activity or as fold change. (see Figure 1 ) 
